Literature DB >> 32267572

TNF Receptor-Associated Factor 6 Mediates TNFα-Induced Skeletal Muscle Atrophy in Mice During Aging.

Jinbo Li1, Xiangjiao Yi1,2, Zhenqiang Yao1, Joe V Chakkalakal3, Lianping Xing1, Brendan F Boyce1,4.   

Abstract

During aging, muscle mass decreases, leading to sarcopenia, associated with low-level chronic inflammation (inflammaging), which induces sarcopenia by promoting proteolysis of muscle fibers and inhibiting their regeneration. Patients with a variety of pathologic conditions associated with sarcopenia, including rheumatoid arthritis (RA), have systemically elevated TNFα serum levels, and transgenic mice with TNFα overexpression (TNF-Tg mice, a model of RA) develop sarcopenia between adolescence and adulthood before they age. However, if and how TNFα contributes to the pathogenesis of sarcopenia during the normal aging process and in RA remains largely unknown. We report that TNFα levels are increased in skeletal muscles of aged WT mice, associated with muscle atrophy and decreased numbers of satellite cells and Type IIA myofibers, a phenotype that we also observed in adult TNF-Tg mice. Aged WT mice also have increased numbers of myeloid lineage cells in their skeletal muscles, including macrophages and granulocytes. These cells have increased TNFα expression, which impairs myogenic cell differentiation. Expression levels of TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase, which mediates signaling by some TNF receptor (TNFR) family members, are elevated in skeletal muscles of both aged WT mice and adult TNF-Tg mice. TRAF6 binds to TNFR2 in C2C12 myoblasts and mediates TNFα-induced muscle atrophy through NF-κB-induced transcription of the muscle-specific E3 ligases, Atrogen1 and Murf1, which promote myosin heavy-chain degradation. Haplo-deficiency of TRAF6 prevents muscle atrophy and the decrease in numbers of satellite cells, Type IIA myofibers, and myogenic regeneration in TRAF6+/- ;TNF-Tg mice. Our findings suggest that pharmacologic inhibition of TRAF6 signaling in skeletal muscles during aging could treat/prevent age- and RA-related sarcopenia by preventing TNFα-induced proteolysis and inhibition of muscle fiber regeneration.
© 2020 American Society for Bone and Mineral Research. © 2020 American Society for Bone and Mineral Research.

Entities:  

Keywords:  INFLAMMAGING; MUSCLE ATROPHY; MUSCLE ENVIRONMENTAL CELLS; NF-κB; RHEUMATOID ARTHRITIS; SARCOPENIA; TNFα; TRAF6

Mesh:

Substances:

Year:  2020        PMID: 32267572      PMCID: PMC7429284          DOI: 10.1002/jbmr.4021

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  60 in total

1.  Cytokine anniversary: TNF trailblazers five centuries apart.

Authors:  Claude Libert
Journal:  Nature       Date:  2015-07-09       Impact factor: 49.962

Review 2.  Crosstalk of reactive oxygen species and NF-κB signaling.

Authors:  Michael J Morgan; Zheng-gang Liu
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

Review 3.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

Review 4.  Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

Authors:  Muhammad Abdullah; Jessica M Berthiaume; Monte S Willis
Journal:  Transl Res       Date:  2017-11-07       Impact factor: 7.012

5.  Metastatic cells can escape the proapoptotic effects of TNF-α through increased autocrine IL-6/STAT3 signaling.

Authors:  Shun Li; Ni Wang; Pnina Brodt
Journal:  Cancer Res       Date:  2011-12-22       Impact factor: 12.701

6.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

Review 7.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

8.  Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.

Authors:  Pradyut K Paul; Sanjay K Gupta; Shephali Bhatnagar; Siva K Panguluri; Bryant G Darnay; Yongwon Choi; Ashok Kumar
Journal:  J Cell Biol       Date:  2010-12-27       Impact factor: 10.539

9.  Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Authors:  Michele Barone; Maria Teresa Viggiani; Maria Grazia Anelli; Rosalinda Fanizzi; Orsola Lorusso; Giuseppe Lopalco; Luca Cantarini; Alfredo Di Leo; Giovanni Lapadula; Florenzo Iannone
Journal:  J Clin Med       Date:  2018-12-01       Impact factor: 4.241

Review 10.  Inflammaging as a prodrome to Alzheimer's disease.

Authors:  Brian Giunta; Francisco Fernandez; William V Nikolic; Demian Obregon; Elona Rrapo; Terrence Town; Jun Tan
Journal:  J Neuroinflammation       Date:  2008-11-11       Impact factor: 8.322

View more
  9 in total

1.  RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice.

Authors:  Fabrizio Pin; Alexander J Jones; Joshua R Huot; Ashok Narasimhan; Teresa A Zimmers; Lynda F Bonewald; Andrea Bonetto
Journal:  J Bone Miner Res       Date:  2021-12-13       Impact factor: 6.390

2.  Leaky gut-derived tumor necrosis factor-α causes sarcopenia in patients with liver cirrhosis.

Authors:  Takumi Kawaguchi; Takuji Torimura
Journal:  Clin Mol Hepatol       Date:  2021-08-26

Review 3.  Induction of Accelerated Aging in a Mouse Model.

Authors:  Nanshuo Cai; Yifan Wu; Yan Huang
Journal:  Cells       Date:  2022-04-22       Impact factor: 7.666

4.  1,25-Dihydroxyvitamin D deficiency induces sarcopenia by inducing skeletal muscle cell senescence.

Authors:  Shuxiang Yu; Biqi Ren; Haiyun Chen; David Goltzman; Jianshe Yan; Dengshun Miao
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 5.  Ubiquitin Ligases at the Heart of Skeletal Muscle Atrophy Control.

Authors:  Dulce Peris-Moreno; Laura Cussonneau; Lydie Combaret; Cécile Polge; Daniel Taillandier
Journal:  Molecules       Date:  2021-01-14       Impact factor: 4.411

6.  TNF Signaling Acts Downstream of MiR-322/-503 in Regulating DM1 Myogenesis.

Authors:  Meng Li; Feng Xu; Zhongxian Liu; Chunguang Wang; Yun Zhao; Guoping Zhu; Xiaopeng Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

7.  TNF-α Suppresses Apelin Receptor Expression in Mouse Quadriceps Femoris-Derived Cells.

Authors:  Tomohisa Koyama; Kentaro Uchida; Makoto Itakura; Masayuki Miyagi; Ryo Tazawa; Gen Inoue; Kensuke Fukushima; Yoshihisa Ohashi; Ayumi Tsukada; Masashi Takaso
Journal:  Curr Issues Mol Biol       Date:  2022-07-08       Impact factor: 2.976

8.  Metabolipidomic profiling reveals an age-related deficiency of skeletal muscle pro-resolving mediators that contributes to maladaptive tissue remodeling.

Authors:  James F Markworth; Lemuel A Brown; Eunice Lim; Jesus A Castor-Macias; Jacqueline Larouche; Peter C D Macpherson; Carol Davis; Carlos A Aguilar; Krishna Rao Maddipati; Susan V Brooks
Journal:  Aging Cell       Date:  2021-06-02       Impact factor: 11.005

Review 9.  Advance in Drug Delivery for Ageing Skeletal Muscle.

Authors:  Yi Li; Ming Chen; Yanpeng Zhao; Ming Li; Yong Qin; Shi Cheng; Yanyu Yang; Pengbin Yin; Licheng Zhang; Peifu Tang
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.